Ginsenoside Rg2 Attenuated Trastuzumab-Induced Cardiotoxicity in Rats

AIM: Trastuzumab (TZM) is a monoclonal antibody drug for HER2-positive breast cancer by targeting epidermal growth factor 2, but it has significant cardiotoxicity. Ginsenoside Rg2 has shown a variety of biological activities. This study was aimed at investigating whether Rg2 attenuates TZM-induced c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guang, Zhang, Jinli, Sun, Fangyi, Ma, Jingtao, Qi, Xiaoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769853/
https://www.ncbi.nlm.nih.gov/pubmed/35071601
http://dx.doi.org/10.1155/2022/8866660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769853/
https://www.ncbi.nlm.nih.gov/pubmed/35071601
http://dx.doi.org/10.1155/2022/8866660

Ejemplares similares